Dr. Keyan Salari: New Study at American Urological Association 2022
Returning guest, Dr. Keyan Salari, a urologic oncologist and surgeon, Co-Director, Prostate Cancer Genetics Program at Massachusetts General Hospital discusses his study “Impact of Family History and Germline Genetic Risk Variants on Long-Term Outcomes of Active Surveillance-Eligible Prostate Cancer” that was presented at AUA 2022.
Frequently Asked Questions
What is the main topic discussed in this episode of Health Professional Radio?
This episode covers important developments in healthcare, including updates on Cancer. Health Professional Radio brings you expert insights and analysis on the latest medical news affecting healthcare professionals and patients alike.
How can healthcare professionals benefit from this information?
Healthcare professionals can stay informed about the latest developments in Cancer and related fields, enabling them to provide better patient care. Staying current with medical news helps clinicians make evidence-based decisions in their practice.
Where can I find more information about Cancer?
For more detailed information, listen to the full episode on Health Professional Radio and visit hpr.fm for additional resources. You can also subscribe to our podcast for regular updates on healthcare news and expert interviews.
Key Takeaways
- Key Point: Keyan Salari, a urologic oncologist and surgeon, Co-Director, Prostate Cancer Genetics Program at Massachusetts General Hospital discusses his study “Impact of Family History an…
- Key Point: He is a urologic surgeon specialized in the treatment of genitourinary cancers using open, laparoscopic, and robotic surgery techniques.
- Key Point: His research focuses on applying cancer genomics and computational biology methods to advance precision cancer medicine for genitourinary malignancies.
- Key Point: Keyan Salari: New Study at American Urological Association 2022
- Healthcare Insight: Stay informed with the latest healthcare news and developments from Health Professional Radio.
Keyan Salari, MD, PhD is a urologic oncologist at the Massachusetts General Hospital and Harvard Medical School. He is a urologic surgeon specialized in the treatment of genitourinary cancers using open, laparoscopic, and robotic surgery techniques. His research focuses on applying cancer genomics and computational biology methods to advance precision cancer medicine for genitourinary malignancies.
Medical Disclaimer
The information provided on this website is for general informational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional for medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.



